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Mutations Affecting the BHLHA9 DNA-Binding Domain
Cause MSSD, Mesoaxial Synostotic Syndactyly
with Phalangeal Reduction, Malik-Percin Type
Sajid Malik,1,2 Ferda E. Percin,3 Dorothea Bornholdt,1 Beate Albrecht,4 Antonio Percesepe,5
Manuela C. Koch,1 Antonio Landi,6 Barbara Fritz,1 Rizwan Khan,2 Sara Mumtaz,2 Nurten A. Akarsu,7
and Karl-Heinz Grzeschik1,*
Mesoaxial synostotic syndactyly, Malik-Percin type (MSSD) (syndactyly type IX) is a rare autosomal-recessive nonsyndromic digit
anomaly with only two affected families reported so far. We previously showed that the trait is genetically distinct from other syndactyly
types, and through autozygosity mapping we had identified a locus on chromosome 17p13.3 for this unique limb malformation. Here,
we extend the number of independent pedigrees from various geographic regions segregating MSSD to a total of six. We demonstrate
that three neighboring missense mutations affecting the highly conserved DNA-binding region of the basic helix-loop-helix A9
transcription factor (BHLHA9) are associated with this phenotype. Recombinant BHLHA9 generated by transient gene expression is
shown to be located in the cytoplasm and the cell nucleus. Transcription factors 3, 4, and 12, members of the E protein (class I) family
of helix-loop-helix transcription factors, are highlighted in yeast two-hybrid analysis as potential dimerization partners for BHLHA9.
In the presence of BHLHA9, the potential of these three proteins to activate expression of an E-box-regulated target gene is reduced
considerably. BHLHA9 harboring one of the three substitutions detected in MSSD-affected individuals eliminates entirely the transcrip-
tion activation by these class I bHLH proteins.We conclude that by dimerizing with other bHLH protein monomers, BHLHA9 could fine
tune the expression of regulatory factors governing determination of central limb mesenchyme cells, a function made impossible by
altering critical amino acids in the DNA binding domain. These findings identify BHLHA9 as an essential player in the regulatory
network governing limb morphogenesis in humans.Introduction
Mesoaxial synostotic syndactyly, Malik-Percin type (MSSD
[MIM 609432]) (syndactyly type IX) demonstrates a
distinctive combination of clinical features that include
mesoaxial osseous synostosis at metacarpal level, reduc-
tion of one or more phalanges, hypoplasia of distal pha-
langes of preaxial and postaxial digits, clinodactyly of
fifth fingers, and preaxial fusion of toes.1 Only two families
with this autosomal-recessive nonsyndromic digit anom-
aly have been reported so far.1–3 Of the nine well-character-
ized nonsyndromic syndactylies, it is the only recessive
type beyond syndactyly type VII, Cenani-Lenz syndactyly
(CLS [MIM 212780]).4,5
Through autozygosity mapping we had identified a
locus on chromosome 17p13.3 for this unique limb
malformation.2 The same chromosomal region harbors a
locus for autosomal-dominant split-hand/foot malforma-
tion and long bone deficiency of variable expression and
incomplete penetrance (SHFLD [MIM 612576]),6,7 which
has recently been shown to be associated with 17p13.3
duplications with a small region of overlap encompassing
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The Americantranscription factor (BHLHA9 [MIM 615416]).8–11 BHLHA9
had been predicted to contain a single exon coding for
a class II basic helix-loop-helix transcription factor.12
It emerges as a candidate gene also for MSSD because it
is specifically expressed in the distal mesenchyme of
E10.5–E11.5 mouse embryo limb buds, when patterning
of digital rays of the autopods is taking place, and homozy-
gous bhlha9 knockout mice displayed various degrees
of simple incomplete webbing of forelimb digits 2–3
involving soft tissue, but not skeletal elements.11,13,14 In
addition, in mild cases, hand malformations associated
with 7p13.3 duplications resemble MSSD.6,10
To identify the gene mutations that cause MSSD, we
recruited additional families from various geographic
regions segregating the trait. Coding exon sequencing
of candidate genes from the region defined by genetic
mapping in a total of six pedigrees detected missense
mutations that were associated with this phenotype
affecting the highly conserved DNA-binding region
of BHLHA9. Basic helix-loop-helix (bHLH) proteins are
transcription factors involved in the regulation of embry-
onic development. They share a basic domain that
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Figure 1. Pedigrees Harboring Subjects
with the Autosomal-Recessive Phenotype
Syndactyly Type IX, Mesoaxial Synostotic
Syndactyly, Malik-Percin Type
For clarity, pedigrees have been trimmed.
Extended pedigrees for families 1 and 2
have been reported previously.1,3 Black
symbols indicate clinically affected indi-
viduals. Haplotypes for the microsatellite
markers from the candidate interval at
chromosome 17p13.3 genotyped in family
3 are depicted. The autozygous region
segregating in the affected subjects is given
in shaded block. A minus sign () shows
the alleles that could not be genotyped.
BHLHA9 missense mutations segregating
in the families are indicated.domain that facilitates homo- or heterodimerization of
HLH protein monomers.15 To support the notion that
missense mutations of BHLHA9 cause MSSD, we set out
to examine functional properties of the protein such as
intracellular localization, to search experimentally for
potential dimerization partners, and to compare the
impact of wild-type versus mutant BHLHA9 protein on
target gene transcription. BHLHA9 abridged the acti-
vating potential of widely expressed E-box proteins
considerably. Because it can likewise bind other cell-
type-specific bHLH proteins, it might sequester them,
thus indirectly influencing gene expression control.
Exchanging critical amino acids in the DNA binding
domain of BHLHA9 destroys these capabilities to fine
tune control of regulatory pathways specifically during
limb development.Subjects, Material, and Methods
Subjects and Families
This study included six multigenerational pedigrees from Turkey,
Pakistan, and Italy (Figure 1). The design of the study was in
accordance with the Declaration of Helsinki protocols. Peripheral
blood samples were collected after informed consent from indi-
viduals listed in Table 1, according to protocols approved by the
participating institutions. Examination of medical records and
mutation analysis procedures followed were in accordance with650 The American Journal of Human Genetics 95, 649–659, December 4, 2014the ethical standards of the respective
national and institutional committees on
human subject research.
Control DNA samples were taken from
79 individuals from Europe and from 61
probands from Pakistan, unrelated to the
families under study. Families 1 and 2
have been reported previously.2 Families
originating from Turkey or Pakistan (Table
1) are, reportedly, geographically distinct
and unrelated. The number of affected
subjects in the reported families varied
from eight to one. We observed a total of
17 affected individuals (9 male, 8 female).Parental consanguinity was reported, in line with autosomal-
recessive inheritance pattern.
Genetic Mapping
In order to check for the cosegregation of the type IX syndactyly
locus (chromosome 17p13.3) with the phenotypes segregating
in family 3, we genotyped highly informative microsatellite
markers from the candidate interval (Table S1 available online).
Procedures for genomic DNA preparation, PCR amplification,
allele separation and calling, and linkage analysis were essentially
the same as described previously.1,2
Haplotype Analysis
To obtain an indication for potential founder mutations, haplo-
types of a selection of 45 common SNPs listed in dbSNP build
138 in a 10.7 kb segment of chromosome 17p13.3 (Table S2),
encasing BHLHA9, were genotyped by DNA sequence analysis in
affected individuals from Turkey and Pakistan carrying identical
BHLHA9 mutations.
Mutation Analysis of Candidate Genes
To screen candidate genes from the defined interval for patho-
genic mutation(s), the coding sequences of FAM57A (RefSeq
accession number NM_024792.1; MIM 611627), TUSC5 (RefSeq
NM_172367.2; MIM 612211), INPP5K (RefSeq NM_130766.2;
MIM 607875) (primer sequences available on request), and
BHLHA9 (RefSeq NM_001164405.1) were PCR amplified. DNA
sequencing was performed on both strands by Sanger sequenc-
ing. Trace chromatogram data were analyzed by Sequencher
Table 1. Probands, Phenotypes, and Genotypes in Six MSSD-Affected Families
Families Phenotypes BHLHA9 Genotypes
Family,
Origin
Affected
Subjects Subject
Affection
Status
Mesoaxial
Reduction
of Finger
Short
Index
Finger Clinodactyly
Preaxial
Toes
Webbing
Mesoaxial
(2/3 Toes)
Webbing
Alleles
BHLHA9
c.211
Alleles
BHLHA9
c.218
Alleles
BHLHA9
c.224
Fam1,
Pakistan,
Punjab
5M, 3F IV-7 A þþ þþ þþ þþ – GG GG GG
IV-5 A þþ þþ þ þþ – GG GG GG
IV-1 A þþ þþ þþ – – GG GG GG
IV-2 A þþ þþ þþ þþ – GG GG GG
II-1 N – – – – – AG GG GG
II-2 N – – – – – AG GG GG
II-5 N – – – – – AG GG GG
III-5 N – – – – – AG GG GG
IV-10 N – – – – – AG GG GG
Fam2,
Turkey
2M, 1F IV-3 N – – – – – AA CG GG
IV-2 N – – – – – AA CG GG
V-3 A þþ þþ þþ þþ – AA CC GG
V-2 N – – – – – AA GG GG
V-1 A þþ þþ – þþ – AA CC GG
III-6 N – – – – – AA CG GG
IV-4 A þþ þþ þþ þþ – AA CC GG
III-7 N – – – – – AA CG GG
Fam3,
Turkey
1M, 1F III-1 N – – – – – AA CG GG
III-2 N – – – – – AA CG GG
IV-2 A þþ þþ þþ þþ – AA CC GG
IV-3 N – – – – – AA GG GG
IV-4 A þþ þþ þþ – þ AA CC GG
IV-5 N – – – – – AA CG GG
Fam4,
Italy,
central
1F IV-1 A þþ þþ þþ – þ AA GG TT
III-1 N – – – – – AA GG TG
V-1 N – – – – – AA GG TG
Fam5,
Pakistan,
Sindh
1F I-2 N – – – – – AA CG GG
II-1 A þþ þþ þþ – – AA CC GG
Fam6,
Pakistan,
KPK
1M, 1F III-4 A þþ þþ þþ – þþ GG GG GG
Abbreviations are as follows: A, affected; N, not affected; M, male; F, female; þþ, bilateral; þ, unilateral.4.7 software (Gene Codes Corp.). Primer pairs and PCR conditions
for the amplification of the single coding exon of BHLHA9 and for
sequence analysis of the PCR products on both strands are listed
in Table S3. Mutations in the coding region of BHLHA9 were
confirmed by independent methods such as an amplification re-
fractory mutation system (c.218G>C [p.Arg73Pro]; families 2, 3,
5; primers in Table S3) and mutation-specific restriction enzyme
digestion (c.211A>G [p.Asn71Asp]; families 1 and 6; with restric-
tion enzyme AjiI; c.224G>T [p.Arg75Leu], family 4, with restric-
tion enzyme SacI). To exclude that the variants represented
SNPs, DNA samples from unaffected family members, 79 unre-The Americanlated control individuals of self-reported European ancestry, and
61 control individuals from Pakistan were scrutinized by the
same procedures, and the sequence of the mutated alleles was
searched in public databases (dbSNP, HapMap, 1000 Genomes,
Exome Variant Server).Molecular Constructs
The translated segment ofHomo sapiens (Hs) basic helix-loop-helix
family member A9 cDNA (BHLHA9) in pCMV6-Entry (C-terminal
Myc and DDK tagged) (pCMV6_HsBHLHA9/wt) and pCMV6-EntryJournal of Human Genetics 95, 649–659, December 4, 2014 651
(C-terminal Myc and DDK tagged) were obtained from OriGene
The translated segments of mutant HsBHLHA9 cDNA (BHLHA9/
N71D, BHLHA9/R73P, BHLHA9/R75L) were amplified by PCR
from genomic DNA of individuals carrying these mutations
(via primers BH_SgfI for, BH_MluI rev; Table S3) and cloned
into the SgfI and MluI sites of pCMV6-Entry to generate
pCMV6_HsBHLHA9/N71D, pCMV6_HsBHLHA9/R73P, and pCMV6_
HsBHLHA9/R75L.
The translated segments of human TCF3 (RefSeq NM_
001136139.2; MIM 147141), TCF4 (RefSeq NM_001083962.1;
MIM 602272), and TCF12 (RefSeq NM_003205.3; MIM 600480)
were isolated by PCR (Table S3) from the potentially complete
cDNA clones (BC110580.1/IRCMp5012E0634D, BC125084.1/
IRCMp5012C034D, and BC050556/IRATp970B1176D, Source
Bioscience) and inserted by TOPO cloning into pCR8/GW/TOPO
(Invitrogen). The inserts of the resulting constructs were shuttled
via Gateway (gw) technology (Invitrogen) into pcDNA6.2/N-
YFP-DEST (Invitrogen) to generate pcDNA6.2/N-YFP-DEST_
HsTCF3, pcDNA6.2/N-YFP-DEST_HsTCF4, and pcDNA6.2/N-YFP-
DEST_HsTCF12. pCMV6-AC-GFP and HsTCF4 in pCMV6-AC-GFP
were obtained from OriGene.
Human TWIST1 andHAND2 cDNAs (BC036704.2; MIM 601622
and BC101406.1; MIM 602407, respectively) in plasmids
pCMV6_HsTWIST1 and pCMV6_HsHAND2 were obtained from
OriGene.
Reporter plasmid 8xEbox-mE5 based on the pGL3 luciferase vec-
tor (Promega) driven by an 8xEbox-mE5 element upstream of a fos
promoter was kindly provided by M. Sigvardsson, Linko¨ping.16
From this vector, the 8xEbox-mE5 element was isolated by PCR
(Table S3) and subsequent HindIII/KpnI digestion, and recloned
into pGL4.23[luc2/minP] (Promega) upstream of a minimal pro-
moter. The control luciferase plasmid pGL4.74[hRLuc/TK] encod-
ing a Renilla-luciferase gene driven constitutively by a thymidine
kinase (TK) promoter was also obtained from Promega. The
structures and insert sequences of all plasmids were verified by
sequencing (Table S3).Histochemical Analysis of Transiently
Transfected Cells
Cos7 cells were maintained under standard conditions in
DMEM_10% (Dulbecco’s Modified Eagle Medium containing Glu-
taMax [Invitrogen], nonessential amino acids, penicillin, strepto-
mycin, supplemented with 10% fetal calf serum). A total of 2 3
105 cells each were seeded in 2 ml of this medium per well of
two-well Lab-Tek chamber slides. After 24 hr, for each of the wells,
transfection complexes composed of 3 ml Attractene (QIAGEN)
and 500 ng DNA of recombinant constructs expressing human
wild-type or mutant HsBHLHA9_MYC/DDK and/or HsTCF4_GFP
fusion proteins were mixed in 120 ml DMEM without serum,
incubated for 20 min at room temperature to allow formation of
transfection complexes, and subsequently added drop wise to
the cells in 2 ml fresh DMEM_10%. The cells with the transfection
complexes were incubated under normal growth conditions. After
24 hr, themediumwas replaced with fresh DMEM_10%, and incu-
bation was continued for 24 hr. After methanol/acetone fixation
of the cells, MYC-tagged BHLHA9 was immunostained with
anti-c-myc mouse IgG monoclonal antibody (Invitrogen/Molecu-
lar Probes: A21270, 1:100) and Alexa Fluor 594 goat anti-mouse
IgG (HþL) (Invitrogen/Molecular Probes: A11005) as secondary
antibody (1:200). Intracellular localization of HsTCF4 could be
detected by fluorescence of the GFP tag. Immunostained cells652 The American Journal of Human Genetics 95, 649–659, Decembwere washed thoroughly with PBS/0.5% Tween 20 and mounted
in ProLong Gold antifade reagent with DAPI for staining of
nuclei (Invitrogen/Molecular Probes). Images were taken on a Zeiss
Axioplan microscope (Carl Zeiss MicroImaging GmbH) with a
Leica DFC 300 FX camera (Leica Microsystems) and processed
with the Leica imaging system 50 (IM50) software.
Luciferase Reporter Gene Assays
The efficiency of enhancing transient expression in Cos7 or in
osteosarcoma-derived U2OS cells of an 8xEbox-enhanced fos-pro-
moter driven pGL3 Firefly luciferase reporter gene16 or an 8xEbox-
enhanced minimal-promoter driven pGL4.23[luc2/minP] Firefly
luciferase reporter gene was tested for HsBHLHA9 wild-type
or mutant proteins alone or in combination with potentially
interacting human bHLH-proteins TCF3, TCF4, TCF12, TWIST1,
or HAND2. A total of 1.5 3 105 Cos7 cells or 2 3 105 U2OS cells
per well were set up in triplicate in 12-well plates in 2 ml
DMEM_10% and incubated at 37C, 5% CO2. After 24 hr, fresh
medium was added, and the cells were transfected by adding to
each well a mixture containing 200 ml serum-free DMEM, 3 ml Tur-
boFect in vitro transfection reagent (Thermo Scientific), 500 ng
each of pGL3 or pGL4.23 Firefly luciferase reporter gene constructs
with or without 8xEbox-enhancer, 500 ng of an expression plasmid
(pCMV6-Entry_Myc/DDK) with or without BHLHA9 cDNA insert,
500 ng each of an expression plasmid (pcDNA6.2/N-YFP-DEST)
with or without human TCF3, TCF4, TCF12, TWIST1, or HAND2
cDNA insert, and 50 ng of pGL4.74 Renilla luciferase expression
plasmid as control for transfection efficiency. After 8 hr at 37C,
5% CO2, incubation was continued in fresh DMEM_10% for
16 hr. After washing the cells twice with PBS, cell lysates were
prepared and analyzed for Firefly- and Renilla-luciferase activities
in a luminometer Auto Lumat LB953 (Berthold Technologies)
with a dual luciferase reporter assay system as suggested by the
supplier (Promega). These triplicate experiments were performed
three times.Results
Clinical Findings in MSSD-Affected Families
Clinical descriptions of families 1 and 2 have been
reported.1–3
Two children in a Turkish sibship of four (family 3) were
affected with Malik-Percin syndactyly. The unaffected
parents were first cousins, suggesting an autosomal-
recessive inheritance (Figure 1, Table 1). The affected
subjects each had four fingers bilaterally. Their short index
fingers showed radial diversion, the third and fourth
fingers were replaced by a single thick digit, and the
fifth fingers showed clinodactyly (Figures 2A and 2C). In
the feet there was partial cutaneous webbing of toes 1–4
(Figures 2B and 2I).
A 50-year-old woman from Central Italy was admitted
to the Hand Surgery Clinic of the University Hospital of
Modena for chronic pain and severe functional limitation
of the thumbs due to bilateral rhizarthrosis of the trapezio-
metacarpal joint. She presented a congenital bilateral
syndactyly of the third and fourth fingers of both hands
with a synostosis of the corresponding metacarpals, a
mild phalangeal shortening (from the proximal to theer 4, 2014
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Figure 2. MSSD Phenotype of Affected
Subjects
(A and B) Hands (A) and left foot (B) of sub-
ject IV-2 from family 3.
(C and I) Hands (C) and feet (I) of subject
IV-4 from family 3.
(D–F) Hands (D), left foot (E), and radio-
gram (F) of subject IV-1 from family 4.
(G and H) Hands (G) and feet (H) of subject
III-4 from family 6.
Pedigrees and phenotypes are presented in
Figure 1 and Table 1.distal) involving all the fingers including the thumb, and a
fifth finger clinodactyly (Figures 1D–1F). A bilateral syn-
dactyly of the second and third toes was also present.
The analysis of the pedigree excluded the presence of
hand malformations in the relatives and revealed consan-
guinity; the parents of the proband were first cousins
(Figure 1, Table 1, family 4). The most affected thumb,
the right, was surgically treated by arthrodesis of the trape-
zio-metacarpal joint with a scarce relief of the symptoms.
Family 5 originates from South Pakistan (Sindh). The
only subject affected with MSSD was a 24-year-old female
with consanguineous parents (Figure 1, Table 1). She pre-
sented with no developmental malformation other than
at the hands. The feet were unaffected. In the family, no
previous history of any limb defect was reported. She had
four digits in both hands; the mesoaxial digits were
missing bilaterally. The fingers were relatively short, hypo-
plastic, and gave an impression of radial deviation. The
fifth fingers were showing clinodactyly, more pronounced
in the left hand. Finger tips were tapering with hypoplastic
nail plates. In the second and fourth digits, the nails were
reduced to small islands, but the nail plates of the first and
last digits were less affected.
In family 6 from the KPK province of Pakistan, there
were two affected subjects (one male, one female), of
which one was deceased (Figure 1). The only affected sub-
ject available for analysis in this kindred was a 23-year-old
male (III-4). He was third in the sibship of five, and his
parents were first cousins once removed. There was no
family history of limb or any other malformation. TheThe American Journal of Human Genindex subject was observed to have
four digits in both hands, and one of
the mesoaxial digits was omitted,
bilaterally (Figure 2G). The thumbs
were short, and the index fingers de-
picted valgus deviations at their ter-
minal phalanx. Additionally, the left
index finger had symphalangism.
The third and fourth fingers were re-
placed by single digit, which demon-
strated broad proximal phalanx,
hypoplastic and club-shaped terminal
phalanx, and reduced nail, bilaterally.
The fifth fingers were dysplastic andexhibited clinodactyly. At the palmar side, characteristic
dermatoglyphic changes were evident, i.e., triradii were
grossly distorted and interdigital flexion creases were less
remarkable. The phenotype in the feet was characterized
by hallux varus, partial zygodactyly between second and
third toes, and shortening of fourth toes, bilaterally
(Figure 2H). The nails of digits 2–4 were hypoplastic.
The trait appeared to be inherited as autosomal recessive
without sex bias. The affected subjects in all six families
had remarkable similarities in their limb phenotypes.
Generally, the phenotype in hands was bilateral and sym-
metrical but was unilateral and asymmetrical in feet.
Roentgenographic examination depicted synostosis of
third and fourth metacarpals, resulting in a single, broad,
and conical proximal phalanx, ending in dysplastic middle
and terminal phalanx. In fifth fingers, there was bilateral
clinodactyly along with symphalangism at middle-distal
phalanx. Distal heads of metacarpals generally showed hy-
poplasia. There was crowding of carpal bones (Figure 2F).
In the feet there was no evidence of bony involvement.
However, hypoplasia of middle and distal phalanx of all
toes was frequently observed.
Genetic Mapping Confirms Candidate Region
Genotyping in family 3 (Figure 1) revealed homozygosity
in both affected subjects IV-2 and IV-4 from microsatellite
markers D17S849 to D17S1533, whereas two unaffected
subjects (IV-3 and IV-5) and the parents (III-1 and III-2)
were heterozygous (Figure 1). Joining of data of this
family and the two families previously reported2 slightlyetics 95, 649–659, December 4, 2014 653
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Figure 3. Mutations Affecting DNA Bind-
ing Sites of Human BHLHA9 and Homolo-
gous bHLH Proteins
(A) Model of human BHLHA9 with depic-
tion of the basic helix-loop-helix region as
indicated in the NCBI Protein database.
(B) Mapping of MSSD-associated missense
mutations to the basic nucleic acid bind-
ing site of BHLHA9 enclosing the E-box
specificity site identified with the CCD
program,35 projected onto an amino acid
sequence alignmentof orthologousBHLHA9
sequences from various vertebrates and of
human (Hsap) TCF3, TCF4, TCF12, TWIST1,
HAND2, and NEUROD1 sequences gener-
ated by ClustalW.36 Numbering of amino
acids refers to human (Hsap) BHLHA9.
NCBI sequence identifiers (gi) are indicated.
The amino acids mutated in the MSSD-
affected individuals (red arrows) are con-
served in all aligned proteins. Species abbre-
viations are as follows: Mmus,Musmusculus;
Ggal, Gallus gallus; Drer, Danio rerio.
(C) Amino acid substitutions in the DNA-
binding region of the basic domain of
helix 1 associated with somatic mutations in cancer listed in the COSM database (green arrows) and/or clinical Mendelian phenotypes
(red arrows).
TWIST1: p.Arg118Cys, in Saethre-Chotzen syndrome (SCS)23 and COSM1449859; p.Gln119Pro, SNP rs104894057, in Saethre-Chotzen
syndrome;23,24 p.Arg120Cys in COSM1269548.
NEUROD1: p.Arg109Leu in COSM719047; p.Glu119Gly in COSM402132; p.Arg111Leu, rs104893649, in diabetes mellitus type II
(NIDDM); p.Arg113His in COSM1217138.
TCF4: p.Arg576Gly, p.Arg576Gln, p.Arg578Pro, p.Arg578His, p.Arg580Trp, p.Arg580Gln in Pitt-Hopkins syndrome (PTHS), references in
Sepp et al.;37 p.Arg578Cys in COSM563719 and COSM1141464.
The association of detrimental missense mutations affecting homologous amino acids in the basic DNA-binding region of these bHLH
proteins with clinical phenotypes adds weight to the notion that the comparable mutations in BHLHA9 cause MSSD.improved the LOD scores in the critical interval on
chromosome 17p13.3. Highest pair-wise scores were
established with microsatellites D17S1533, D17S695, and
D17S926, respectively, at Q ¼ 0.0 (Table S1).
Detection of Functionally Detrimental Mutants
Suggests that BHLHA9 Is Altered in MSSD
Out of 19 RefSeq genes predicted in the candidate inter-
val, four candidate genes coding for potentially regulatory
proteins were chosen for mutation analysis by sequencing
DNA of affected individuals. No potentially pathogenic
change was observed in the coding regions of FAM57A,
TUSC5, and INPP5K. However, mutation analysis in
BHLHA9, coding for a bHLH protein, revealed three
different sequence variants homozygous only in affected
subjects (9 males, 8 females) and heterozygous in the un-
affected parents (c.211A>G [p.Asn71Asp], families 1 and
6; c.218G>C [p.Arg73Pro], families 2, 3, 5; c.224G>T
[p.Arg75Leu], family 4). None of the unaffected sibs was
homozygous for these mutations, suggesting complete
penetrance (Figure 1, Table 1, Figure S1). The mutations
were confirmed by independent methods (Figure S2).
These sequence variants were not observed in 280 chro-
mosomes analyzed from a panel of healthy European
and Asian individuals. Likewise, they are not listed in
SNP databases (dbSNP, 1000 Genomes, HapMap, Exome
Variant Server).654 The American Journal of Human Genetics 95, 649–659, DecembThe putative only coding exon of BHLHA9 determines
a highly conserved basic helix-loop-helix protein. The
three mutations observed in the MSSD-affected families
are positioned in close proximity and exchange critical,
conserved amino acids of the DNA-binding region of
the basic domain (Figure 3). Prediction programs classify
all three variants to be probably damaging (Table S4).
Affected Individuals from Families Carrying an
Identical Mutation Share 17p13.3 Haplotypes
Genotypes of 45 common SNPs in a 10.7 kb segment
of chromosome 17p13.3, encasing BHLHA9, each were
identical in affected individuals of families 1 and 6
(c.211A>G [p.Asn71Asp]) from Pakistan and families 2
and 3 (c.218G>C [p.Arg73Pro]) from Turkey, respectively
(Table S2). Different alleles were detected in the haplo-
type of an affected person with the mutation c.218G>C
(p.Arg73Pro) in family 5 from Pakistan.
BHLHA9 Can Bind TCFs, HAND2, and TWIST1
In Y2H screens of d11 and d17 mouse embryo libraries,
three quarters of the interactions with a BHLHA9 bait
were detected with TCF3, TCF4, and TCF12 (Table S5).
Other preys were detected only once or were considered
false-positive hits (data not shown). The dimerization of
human TCF proteins with HsBHLHA9 was confirmed
by one-to-one Y2H (Figure S4). Likewise, one-to-one Y2Her 4, 2014
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Figure 4. Luciferase Assays Demonstrate Regulatory Activity of Coexpressed BHLHA9 and TCFs
Transient cotransfection into Cos7 cells of a construct encoding human wild-type (BH_WT) or mutant BHLHA9 (BH_N71D, BH_R73P,
BH_R75L) in expression vector pCMV6-Entry/C-Myc_DDK (pCMV6), with (A) human TCF3 (TCF3), (B) human TCF4 (TCF4), or (C)
human TCF12 (TCF12) in expression vectors pcDNA6.2/N-YFP-DEST (6.2YFP), and a pGL3-derived luciferase reporter gene under
transcriptional control of the mouse fos-promoter with an enhancer element encompassing eight E-box sequences (8xEbox). Transient
expression of BHLHA9_WT alone has no effect on luciferase activity levels. The TCFs, individually, act as strong activators. Cotransfec-
tion with BHLHA9 reduces luciferase activity levels considerably. Replacing expression of BHLHA9_WT with any of the three mutant
DNAs detected in MSSD-affected individuals abolishes reporter gene activation in combination with TCF3, TCF4, and TCF12.
Transfection efficiency is normalized to cotransfected Renilla luciferase. The values obtained in transfection experiments with 8xEbox
and the empty expression vectors (6.2YFP and pCMV6) are set at 0.2, and the other values are adapted accordingly. The results shown
are representative of three independent experimental series, eachwith triplicate transfection experiments. Normalized luciferase activity
(8xEbox-Luc/Ren-Luc) data are represented as mean 5 SD. Repeating these experiments with a pGL4.23 derived reporter construct
employing a minimal promoter did not generate significantly different results (data not shown). Repeating these experiments with
osteoblast-derived cells U2OS generated results comparable to the ones obtained with Cos7 cells (Figure S5).analyses showed that HsBHLHA9 can bind humanHAND2
and TWIST1 (Figure S4). Strongest interactions, as deter-
mined by growth at stringency of 25 mM 3at, were
observed with HsTCF12.
BHLHA9 Tunes the Activation Potential of E-box
Protein Transcription Factors
Myc-tagged BHLHA9 produced by transient gene expres-
sion in Cos7 cells was localized both in the cytoplasm
and in the cell nucleus. This localization was not affected
by any of the mutations observed in MSSD-affected indi-
viduals. In contrast, YFP-tagged TCF4 was detected only
in the cell nucleus (Figure S3). In Cos7 cells, expression
of a human BHLHA9 transgene alone was insufficient to
activate above control the expression of luciferase reporter
constructs enhanced by E-box sequences upstream of fos-
or minimal promoters (Figure 4). In contrast, human
TCF3, TCF4, and TCF12 acted as strong activators. This
activation was reduced 20–40 times, when the cDNAs
coding for these class I bHLH proteins were cotransfected
with BHLHA9 (Figure 4). When wild-type BHLHA9 was
replaced by cDNAs carrying mutations c.211A>G,The Americanc.218G>C, or c.224G>T, respectively, the potential of
the three TCF proteins to activate reporter gene expression
was extinguished (Figure 4). In osteosarcoma-derived
U2OS cells, essentially, a comparable pattern emerged. In
contrast to Cos7 cells, transfection of wild-type BHLHA9
alone resulted in a small amount of luciferase activity
(Figure S5). Possibly, these cells express endogenous
bHLH transcription factors able to interact with BHLHA9.
To test for a graded response to the level of mutants, a se-
ries of coexpression experiments with plasmids encoding
human TCF3, TCF4, or TCF12 with plasmids encoding
wild-type BHLHA9 alone, mutant BHLHA9 alone, or com-
bined equal amounts of both wild-type and mutant
BHLHA9 was analyzed by the luciferase assay in Cos7
cells. Compared to cotransfection of plasmids encoding
wild-type BHLHA9 with plasmids encoding any of the
TCFs, cotransfection of plasmids encoding wild-type
and mutated BHLHA9 together with a plasmid encoding
TCF decreased reporter signal levels approximately by
one-third (Figure S6).
Like BHLHA9, both human HAND2 and TWIST1 ex-
pressed individually showed no impact on luciferaseJournal of Human Genetics 95, 649–659, December 4, 2014 655
activity levels. Combination of HAND2 and TWIST with
BHLHA9, likewise, had no activating effect (data not
shown).Discussion
The DNA-Binding Region of BHLHA9 Is Affected in
MSSD-Affected Individuals
Clinical findings in affected persons from six families
segregating MSSD showed a distinctive combination of
developmental peculiarities in hands and feet (Figure 2,
Table 1), suggesting that a gene involved in definition/
separation of individual finger rays in the median segment
of the limb bud is affected. We confirm the mapping of
the MSSD locus to chromosome 17p13.3 and present evi-
dence that missense mutations in BHLHA9 are associated
with this phenotype. These substitutions (p.Asn71Asp,
p.Arg73Pro, and p.Arg75Leu) affect neighboring amino
acids in the DNA binding basic domain of the protein.
This region of the transcription factor is highly conserved
in evolution (Figure 3). With a sequence of 235 amino
acids, BHLHA9 is small and contains in addition to the
bHLH domain, a potentially functionally relevant pro-
line-rich carboxyl terminus. Haplotype analysis of affected
persons from different families carrying the samemutation
suggests the presence of founder mutations (Table S2).
Whereas the variant c.224G>T (p.Arg75Leu), so far, was
observed in only one family of European ancestry, the
presence of identical haplotypes each associated with a
different BHLHA9 mutation in two reportedly unrelated
families from Pakistan and two families from Turkey,
respectively, hints at no fewer than three founder muta-
tions in the Middle East.Missense Mutations Exchanging Homologous Amino
Acids in Potential Dimerization Partners for BHLHA9
Elucidate Functional Defects Underlying MSSD
The amino acids Asn71, Arg73, and Arg75, affected in
MSSD, are identical in the BHLHA9 orthologs in verte-
brates as well as in many other bHLH proteins, such as
TCF3 (E12/E47), TCF4, TCF12, TWIST1, HAND2, and
NEUROD1 (Figure 3). Y2H analysis indicates that BHLHA9
is able to interact (dimerize) with itself, the bHLH E-box
proteins TCF3, TCF4, and TCF12, as well as with TWIST1
and HAND2 (Figure S4). Like these proteins,17 YFP-tagged
wild-type or mutant BHLHA9 proteins localize in the
nucleus of transfected cells in addition to the cytoplasm
(Figure S3). No nuclear localization signal is predicted for
BHLHA9; however, with a mass of 24,132 Da, the protein
might enter the nucleus by passive transport.
The TCFs encode widely expressed bHLH E-box proteins
that heterodimerize with cell-specific bHLH proteins such
as BHLHA9, TWIST1, HAND2, or NEUROD1. E-box pro-
teins are potent regulators of gene expression that bind
on E-box-containing promoters. The heterogeneity in the
E-box sequence that is recognized and the dimers formed656 The American Journal of Human Genetics 95, 649–659, Decembby different bHLH proteins determines how they control
diverse developmental functions through activating or
repressing transcriptional regulation.18
By using a transactivation assay, we found that expres-
sion of BHLHA9 alone did not significantly enhance
expression of a fos- or minimal promoter-driven reporter
gene containing eight E-boxes.16 Combination of native
BHLHA9 with each of the three E-box proteins strongly
reduced reporter gene expression relative to homodimers
of each. The activation by the E-box proteins was com-
pletely blocked in the presence of the BHLHA9 missense
mutations encoding the p.Asn71Asp, p.Arg73Pro, and
p.Arg75Leu substitutions (Figures 4 and S5).
Our observations are congruent with the functional con-
sequences of substitutions of these invariant orthologous
amino acids reported for other bHLH proteins (Figure 3).
Mutations affecting in the E-box protein TCF4 amino
acids orthologous to the ones described here for BHLHA9
cause Pitt-Hopkins syndrome (PTHS [MIM 610954]).19–22
Their substitution in TWIST1 and NEUROD1 causes
Saethre-Chotzen syndrome (SCS [MIM 101400])23,24 and
type II diabetes mellitus (NIDDM [MIM 125853]), respec-
tively. In addition, the Catalogue of Somatic Mutations
in Cancer (COSMIC)25 lists missense mutations in tumor
cells affecting these sites (Figure 3).
It should be noted that the mutations affecting the
orthologous amino acids in the DNA-binding regions of
TCF4, TWIST1, and NEUROD1 cause dominant pheno-
types whereas MSSD is recessive.
Individuals heterozygous for one of the described
BHLHA9 mutations do not have MSSD. Accordingly,
luciferase assays employing coexpression of human TCF3,
TCF4, or TCF12 with equal amounts of wild-type and
mutant BHLHA9 demonstrated a decrease in reporter
gene expression, compared to BHLHA9wt/TCF alone, but
not complete loss of activation (Figure S6).
By analogy to functional consequences reported for
missense mutations altering conserved amino acids in
identical positions of the basic DNA-binding domains of
bHLH proteins,26 we assume that BHLHA9 might likewise
act in limb development as a dimerization partner of
the TCFs or other E-box-binding proteins and that the
detrimental effect of the BHLHA9 missense mutations on
limb development might be caused by the complete loss
of the regulatory potential of the dimers.
Syndactyly phenotypes associatedwithmutations affect-
ing other bHLH proteins, such as MYCN (MIM 164840),
suggest further candidates that might be fine tuned by
dimerizing with BHLHA9.27
Similar Hand Phenotypes in Individuals Mildly
Affected by CLS and MSSD
Cenani-Lenz syndactyly, the second autosomal-recessive
syndactyly, is associated with mutations in low-density
lipoprotein-related protein 4 receptor (LRP4 [MIM
604270]) on chromosome 11p11.2-q13.1, resulting in
deregulated canonical WNT signaling.28er 4, 2014
Affected persons from six families that demonstrated
MSSD associated with BHLHA9mutation showed a distinc-
tive combination of developmental peculiarities in hands
and feet (Figure 2), but no features such as prominent
forehead, hypertelorism, downslanting palpebral fissures,
micrognathia, and kidney anomalies, which have been
reported in Cenani-Lenz syndrome.28–30 The MSSD limb
phenotype is more uniform in contrast to the malforma-
tions in CLS, which range from partial to total syndactyly
and bone malformations of both hands and feet. Notably,
in some CLS individuals, a mild hand phenotype reminis-
cent of MSSD appears.30,31 This partial phenotypic overlap
suggests involvement of a regulatory pathway involved in
limb development that is influenced by both LRP4 and
BHLHA9. LRP4 mutations interfere with the WNT1/b-Cat-
enin-TWIST1 signaling chain, particularly in cells prone
to apoptosis in the median segment of the limb bud.28,31
This signaling plays a key role in the mouse limb bud,
establishing a pattern of graded strength of SHH signaling
across the anterior-posterior dimension.32,33 Under the
influence of SHH from the ZPA, separate digits are pro-
duced by regression of interdigital tissue via apoptosis,
dependent on BMP signaling within the interdigital tissue.
Disruption of this process can result in syndactyly.32
Altered BHLHA9 might interfere with this function,
perhaps by the similarity with the bHLH proteins TWIST1
and its antagonist HAND2. Both are able to bind BHLHA9,
as demonstrated in Y2H analysis (Figure S4), and one or
both might compete with BHLHA9 for the same partners
for dimerization. However, direct functional interaction
is unlikely because in the experimental system employed
here, dimers of these proteins with wild-type or mutant
BHLHA9 did not influence reporter gene expression in
transfected cells (data not shown). Experimental evidence
for a mechanistic link between LRP4 and BHLHA9 has to
be awaited.
Which one of the potential bHLH dimerization partners
for BHLHA9 is chosen during limb development, and
whether any of the postulated mechanisms are responsible
for the loss of function causing the specific malformations
of MSSD await future experimental clarification.
Different Clinical Phenotypes Associated
with BHLHA9 Malfunction
In addition to MSSD associated with BHLHA9 missense
mutations in the DNA-binding domain, involvement of
this protein in the regulation of osteoblast differentiation
in themedian segment of the distal limb budmesenchyme
is suggested by the phenotypes observed with copy-num-
ber variants (CNVs) of chromosome 17p13.3 in humans
or studies in model organisms.
In humans, hemizygous duplications of 17p13.3 seg-
ments are associated in non-Mendelian fashion with
split-hand/foot malformation with long-bone deficiency
(SHFLD3), and the smallest region of overlap, encasing
only BHLHA9, defines this gene as a strong candidate for
the bone phenotypes.6,8–11,34The AmericanThe high degree of nonpenetrance and a sex bias are
attributed to modifiers not identified yet.11,34 The notion
that functional deficiency of BHLHA9 might be respon-
sible for SHFLD3 is also compatible with the limb expres-
sion pattern of this gene restricted to the mesenchyme
underlying the apical ectodermal ridge in mouse and
zebrafish embryos11,14 and with the expression of a LacZ
reporter gene replacing the coding region of Bhlha9 in
Bhlha9 (Fingerin)/lacZ knockout/knockin mice.13 Bhlha9
knockdown in zebrafish results in shortening of pectoral
fins.11 Most of homozygous Bhlha9 (Fingerin)Null mice dis-
played various degrees of simple incomplete webbing of
forelimb digits 2–3 involving soft tissue. Incomplete finger
separation was detectable already during embryogenesis
and correlated with reduced interdigital apoptosis.13
Both missense mutations in humans and knockout of
the coding exon in mice, expected to result in complete
absence of BHLHA9, generate limb malformations only
in homozygotes. However, the molecular consequences
for function of a dimerizing partner bHLH protein are
different (Figures 4 and S5), as are the phenotypes in
mice or humans. Whereas MSSD associated with exclusive
presence of BHLHA9 with deficient DNA-binding capacity
demonstrates a distinctive combination of clinical features
which include mesoaxial osseous synostosis at metacarpal
level, reduction of one or more phalanges, hypoplasia of
distal phalanges of preaxial and postaxial digits, clinodac-
tyly of fifth fingers, and preaxial fusion of toes, complete
absence of the Bhlha9 coding sequence in knockout mice
results in a less severe and different type of syndactyly,
i.e., webbing of forelimb digits 2–3 without bone fusion.
In contrast, SHFLD3 is dominant. Part of the spectrum of
phenotypic entities resulting from duplications of 17p13.3
are associated with the different length of the microdupli-
cations, encasing flanking genes in addition to BHLHA9,
and will not be discussed here. The wide range of SHFLD3
limb phenotypes is considered to be specifically associated
with a detrimental effect of the gene duplication on
BHLHA9 function. In rare cases, the syndactyly in individ-
uals heterozygous for BHLHA9 duplications is reminiscent
of the MSSD phenotype, but these CNV carriers, in addi-
tion, exhibit a split hand.6,10 These phenotypically similar
cases suggest that the functional outcome of the malfunc-
tioning BHLHA9 should be similar to the consequences of
a third gene copy.
In the cotransfection experiments, wild-type BHLHA9
diminished the transcription-activating potential of type
I E-box-binding proteins considerably, leaving only a small
amount of residual activity (Figures 4 and S5). BHLHA9
proteins with dysfunctional DNA-binding sequences did
not retain this fine-tuning regulatory potential but rather
extinguished gene activation. Likewise, increasing the
amount of available inhibitory wild-type BHLHA9 by us-
age of a third gene copy might further reduce transcription
of sensitive target genes. The high degree of nonpene-
trance in SHFLD3 might be associated with allelic hetero-
geneity in the dimerizing bHLH partners, in the targetJournal of Human Genetics 95, 649–659, December 4, 2014 657
gene regulatory domains, or with stochastic differences in
the transcription and translation of overdosed BHLHA9
copies.
This model is open to analysis of the physiological role
of BHLHA9 in the limb bud and to quantification of this
function in models of SHFLD3 and MSSD. It should be
noted that the presence of only one single exon of
BHLHA9 is speculative and that the start and end of tran-
scription as well as the regulatory environment of this
gene are undetermined. Genetic studies with models
featuring missense mutations identical to the ones found
in MSSD are needed to shed light on the consequences
of deficient BHLHA9 DNA binding domains on the well-
established transcription factor network governing limb
patterning.Supplemental Data
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